3rd Quarter - Report

DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE

Firm
Client
Income
—
Expenses
$87,644
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Law Enforcement/Crime/Criminal Justice LAW

S 1689, Marijuana Justice Act S.3032, Strengthening the Tenth Amendment Through Entrusting States Act Issues related to ending federal marijuana prohibition S.1917, Sentencing Reform and Corrections Act of 2017

LobbyistCovered position, as disclosed
QUEEN ABIMBOLA ADESUYI —
MICHAEL COLLINS —
GRANT SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1917 (115th), S. 3032 (115th)

Health Issues HCR

HR 2851, SITSA Act, issues related to synthetic drugs. Issues related to drug overdose. Issues related to collateral consequences of a drug conviction.

LobbyistCovered position, as disclosed
MICHAEL COLLINS —
GRANT SMITH —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2851 (115th)

Budget/Appropriations BUD

Issues related to marijuana-related policy in federal appropriations. Issues related to treatment provided in criminal justice settings and related policy in federal appropriations. Issues related to funding for harm reduction and treatment in federal appropriations.

LobbyistCovered position, as disclosed
MICHAEL COLLINS —
MICHAEL LISZEWSKI New —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.